Digital Solutions for Medical Affairs Teams

Effectively reach patients, HCPs, sponsors, authorities, and more

Learn More
international marketing

Digital and technology-backed workflows to assist with content, localization, and management of medical affairs content

Historically, pharmaceutical companies have organized the medical affairs department regionally instead of globally by therapeutic area. While this structure may be closer to constituents, it can produce substantial regional differences in how organizations communicate medical information to patients and other stakeholders, potentially affecting the patient and stakeholder experience.

Evolve your medical affairs communications from a regional to global, integrated model with TransPerfect Life Sciences’ tptdigital solution for Med Affairs teams.

360 Workflow Solutions To Meet Your Medical Affairs Initiatives

  • Content creation & adaption
  • SEO best practices
  • SEM global strategies
  • Social media management & strategy
  • Multilingual video creation
tpt dig

Enhancing Communications Globally for Key Stakeholders

Attract and keep your target audience’s attention with our specialized digital division’s support

Improve customer engagement through innovative digital solutions and interactive content

News and Press Releases

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations.

Redefining the Role of Medical Affairs with Digital Transformation

Redefining the Role of Medical Affairs  Medical Affairs has long served as the bridge between clinical development, regulatory functions, and the healthcare providers who ultimately deliver therapies to patients. Today, that role is expanding as digital transformation reshapes how information is shared, how evidence is generated, and how patients experience the process of care. Medical Affairs is no longer a static function—it is becoming a strategic driver of ...

Redefining the Role of Medical Affairs with Digital Transformation

LifeSci Talks COA Series | Meaningful Patient Involvement in HTA Decision-making: Where do we go from here?

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Alice Biggane, Outcomes Innovation and Research Lead at Pfizer, to discuss how PRO measures inform and impact endpoint adjudication and reimbursement decisions, due ...

Patient Recruitment Strategies: Empowering Patients Through Accessible Information

From pre-screen to post-trial, patients require clear, personalized and supportive communication to navigate the clinical trial journey. Despite the industry’s recognition of patient centricity and the abundance of digital health solutions, many trial participants still struggle ...

Generative AI Strategies for Life Sciences: Creating Content that Performs, Complies, and Resonates

Shaping the Conversation Around AI Everywhere you look, people are talking about generative AI. The hype is hard to escape, but in life sciences, the conversation quickly shifts from excitement to hesitation. How do you embrace AI in an industry where compliance, data...

Digital Transformation Fireside Chat

In this fireside chat, Christine Buggle-Spearing and Dr. Gigi Shafai, Pharm.D., from TransPerfect Life Sciences, share practical strategies for modernizing medical affairs processes. The discussion covers how to design a digital-first strategy that creates value for both patients ...

Integrating eCOAs and Digital Health Technologies for Patient-Centric Trials

The foundation of patient-first design is technology that connects seamlessly to support and meet patients where they are. In this session, leaders from Pfizer, THREAD, Datacubed, Obvio Health, and Merative will discuss how integrated digital ecosystems are breaking down platform ...

How Patients Discover Clinical Trial Websites: The Role of Localization in Accessibility

Patient recruitment strategy is becoming faster, broader, and more inclusive than ever. Yet many clinical trial websites still overlook two critical factors that determine whether patients can find and engage with trial opportunities: accessibility and localization. Together,...

Ready to Enhance Your Relationship with Key Stakeholders?

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.